China+1 vs. Full Reshoring: Which Strategy Fits Your Business?
April 23, 2026
China+1 vs. Full Reshoring: Which Strategy Fits Your Business?
The era of single-source dependence on Chinese manufacturing is closing. Between escalating tariffs, geopolitical tension, IP concerns, and the pandemic-era lesson that lean supply chains break under stress, US companies are rethinking where their products get made. But the path forward isn't uniform. Some businesses are hedging with a China+1 strategy, keeping partial production in China while adding a second country. Others are pursuing full reshoring, exiting China entirely in favor of US or Mexican manufacturing.
Which approach fits your business depends on volume, margin, IP sensitivity, tariff exposure, and how much operational change your team can absorb. At Reshore, we help companies navigate this decision every day — and the right answer is rarely as simple as "just move everything."
What Is the China+1 Strategy?
The China+1 strategy is a supply chain diversification approach where companies keep a portion of their manufacturing in China while adding production capacity in at least one additional country — typically Vietnam, India, Mexico, Thailand, or the United States. The goal is risk mitigation without the upfront cost and disruption of a full exit.
First popularized after the 2018 US-China trade war, China+1 gained renewed urgency after COVID-19 lockdowns exposed the fragility of concentrated sourcing. According to a Reuters analysis, more than 60% of multinationals surveyed in 2025 reported either actively implementing or planning a China+1 approach.
Why Companies Choose China+1
- Lower upfront disruption: Existing Chinese supplier relationships, tooling, and processes remain intact.
- Tariff hedging: A portion of production moves outside Section 301 tariff exposure.
- Capacity flexibility: Second-country suppliers can scale up if China access is restricted.
- IP risk reduction: Sensitive products can be moved out of China while commodity items stay.
What Is Full Reshoring?
Full reshoring means relocating 100% of your manufacturing from China to domestic (US) or nearshore (Mexico) operations. It's a more aggressive strategy that eliminates China exposure entirely — along with the tariffs, shipping lead times, IP risk, and geopolitical volatility that come with it.
Full reshoring typically involves:
- Tooling transfer from Chinese factories to US or Mexican facilities
- Supplier re-qualification with new manufacturers
- Process validation for injection molding, assembly, and quality systems
- Logistics redesign around Americas-based freight corridors
For companies making this move, our Mold Transfer from China to Mexico playbook covers the legal, technical, and logistical mechanics in detail.
China+1 vs. Full Reshoring: Side-by-Side Comparison
| Factor | China+1 | Full Reshoring |
|---|---|---|
| Upfront investment | Low to moderate | Moderate to high |
| Time to implement | 6–12 months | 9–18 months |
| Tariff exposure reduction | Partial (30–50%) | Complete |
| IP risk reduction | Partial | Complete |
| Supply chain complexity | Higher (multiple regions) | Lower (consolidated) |
| Lead time improvement | Marginal | Significant (weeks → days) |
| Best for | High-volume, low-margin goods | IP-sensitive, regulated, or tariff-heavy products |
| Cash flow impact | Gradual | Front-loaded, then improved |
| Ongoing China dependency | Yes | No |
When China+1 Is the Right Strategy
China+1 makes sense when your business has high-volume, commoditized products where Chinese unit economics still win even after tariffs, and where disruption to existing operations would be costlier than the risk of staying. Consider China+1 if:
- Your tariff exposure is under 15–20% of landed cost
- Your products have minimal IP sensitivity
- You need production continuity during any transition
- Your internal team lacks bandwidth for a full migration
- You serve global markets where Asian distribution is critical
A common China+1 pattern we see: companies keep their highest-volume SKUs in China while shifting new product launches, regulated categories (medical, automotive), and high-margin variants to Mexico or the US.
When Full Reshoring Is the Right Strategy
Full reshoring tends to be the right move when the hidden costs of China manufacturing outweigh the unit-price savings. That includes tariffs, freight volatility, quality remediation, IP leakage, and the executive time consumed managing a 12-hour time difference.
Full reshoring fits when:
- Tariff exposure exceeds 25% of landed cost
- Products are IP-sensitive (proprietary designs, trade secrets, regulated devices)
- Lead times materially impact revenue (fashion, electronics, seasonal goods)
- Your end customer prefers or requires "Made in USA" or USMCA-compliant sourcing
- You're already experiencing quality or communication friction with Chinese partners
- Your product qualifies for Section 301 exclusions or USMCA preferential treatment
Medical device companies are a particularly strong fit — regulatory validation costs are significant enough that doing it twice (China+1) rarely pencils out versus doing it once in Mexico. We cover this in depth in our Medical Device Manufacturing: China to Mexico Migration Guide.
Reshoring vs. Nearshoring: A Quick Clarification
The terms reshoring vs nearshoring are often used interchangeably, but they're different:
- Reshoring: Bringing manufacturing back to the United States.
- Nearshoring: Relocating manufacturing to a geographically close country — most commonly Mexico for US-bound goods.
For plastic injection molding specifically, Mexico has emerged as the dominant nearshore destination thanks to USMCA duty-free treatment, mature tooling ecosystems in Querétaro, Monterrey, and Guadalajara, and labor costs 60–70% below US rates. Most "reshoring" decisions we see today are actually hybrid US+Mexico strategies, with complex assembly or regulated finishing happening stateside and high-volume molding in Mexico.
For a data-driven breakdown, see our Mexico vs. China Manufacturing comparison on cost, lead time, and quality.
How to Decide: A Practical Framework
Ask these five questions to clarify which strategy fits:
- What's your total tariff exposure today? Calculate landed cost with all Section 301 duties, not just the base rate. Under 15% favors China+1; over 25% favors full reshoring.
- How sensitive is your IP? Proprietary molds, formulations, or designs argue strongly for full exit.
- What's your volume profile? Millions of units of a commodity part may still make sense in China. Tens of thousands of a specialized SKU usually doesn't.
- What does your customer care about? B2B buyers increasingly require nearshore or USMCA sourcing. B2C brands are leveraging "Made in USA" marketing.
- What's your team's change capacity? Full reshoring requires executive sponsorship and 9–18 months of focused program management. China+1 is lighter-touch but creates long-term complexity.
Where Reshore Fits
We at Reshore built our AI-powered platform specifically because this decision — and the execution that follows — is too complex for spreadsheet-driven sourcing. Whether you choose China+1 or full reshoring, the hard parts are the same: matching your tooling and volume to the right factory, transferring molds without damage or delay, validating quality, and building logistics that work.
Our platform handles factory sourcing, supplier matching, tooling transfer coordination, and production setup across Mexico and the US. If you're evaluating your options, a reshoring assessment can quantify your tariff exposure, identify candidate suppliers, and model the cost of each path before you commit.
The Bottom Line
There's no universally correct answer between China+1 and full reshoring. The right choice depends on your product economics, IP profile, customer requirements, and organizational readiness. What is universally true: sticking with a single-source China strategy is no longer defensible risk management. The companies that move deliberately now — with clear data and coordinated execution — will be the ones with resilient supply chains when the next disruption hits.
Frequently Asked Questions
Q: What does "China+1" actually mean in practice?
China+1 means maintaining your existing Chinese manufacturing base while adding production capacity in at least one additional country to reduce concentration risk. In practice, most companies split SKUs by category — keeping commoditized, high-volume items in China and moving new launches, IP-sensitive products, or tariff-heavy goods to a second country like Mexico or Vietnam.
Q: Is China+1 cheaper than full reshoring?
In the short term, yes — China+1 has lower upfront costs because you're not retiring existing tooling or supplier relationships. Over a 3–5 year horizon, however, full reshoring often produces lower total landed costs once tariffs, freight volatility, inventory carrying costs, and quality remediation are factored in. A proper cost model should compare both options over at least three years.
Q: How long does it take to diversify supply chain away from China?
A typical China+1 implementation takes 6–12 months from supplier identification to qualified production. Full reshoring usually takes 9–18 months, with injection molding tooling transfers representing the critical path. Regulated products (medical, automotive) can extend timelines by 3–6 months due to validation requirements.
Q: What's the difference between reshoring and nearshoring?
Reshoring brings manufacturing back to the United States. Nearshoring relocates it to a geographically close country — for US companies, that almost always means Mexico. Many "reshoring" programs are actually hybrid, combining US final assembly with Mexican injection molding and component manufacturing to capture labor cost advantages while staying within USMCA.
Q: Does Reshore help with both China+1 and full reshoring strategies?
Yes. Our platform supports both approaches, though we specialize in moving plastic manufacturing and injection molding operations from China to Mexico and the US. Whether you need to add one nearshore supplier or relocate your entire production footprint, our AI-powered sourcing engine matches your tooling and volume requirements to verified Americas-based manufacturers.
Q: How does Reshore handle tooling transfer from Chinese suppliers?
We at Reshore coordinate the full tooling transfer process — including legal documentation, mold inspection and refurbishment, international freight, and process validation at the receiving factory. Our team manages the supplier negotiations that are often the hardest part of extracting tooling from Chinese manufacturers who may resist losing the business.
Q: What industries benefit most from full reshoring versus China+1?
Medical devices, aerospace components, defense-related products, and IP-sensitive consumer electronics typically benefit most from full reshoring due to regulatory, security, and IP considerations. High-volume consumer goods, toys, textiles, and commodity plastic parts often fit better with China+1, where Chinese unit economics remain competitive even with tariffs applied.